Antibiotic Prophylaxis in Vaccinated Eculizumab Recipients Who Developed Meningococcal Disease

Overview

Journal J Infect

Specialty Infectious Diseases

Date 2019 Nov 30

PMID 31783062

Citations 8

Authors

Page E Crew

Lucy McNamara

Peter E Waldron

Lynda MCCulley

S Christopher Jones

Susan J Bersoff-Matcha

Affiliations

Soon will be listed here.

Citing Articles

Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy.

Starck L, Nummi V, Poikonen E, Lehtinen A, Kivela P, Friberg N Emerg Infect Dis. 2025; 31(3):583-586.

PMID: 40023814 PMC: 11878301. DOI: 10.3201/eid3103.241182.

Progression of antibiotic resistance in .

Rodriguez E, Tzeng Y, Berry I, Howie R, McNamara L, Stephens D Clin Microbiol Rev. 2025; 38(1):e0021524.

PMID: 39887238 PMC: 11905363. DOI: 10.1128/cmr.00215-24.

Meningococcal Carriage in Children with Atypical Hemolytic Uremic Syndrome Receiving Eculizumab Therapy.

Kavaz Tufan A, Ozak Batibay F, Aksoy G, Gulhan B, Demircioglu Kilic B, Dursun I Children (Basel). 2024; 11(10).

PMID: 39457129 PMC: 11506456. DOI: 10.3390/children11101164.

Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies.

Urra M, Lyons S, Teodosiu C, Burwick R, Java A Kidney Int Rep. 2024; 9(8):2353-2371.

PMID: 39156177 PMC: 11328568. DOI: 10.1016/j.ekir.2024.05.016.

Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome.

Doubrovinskaja S, Korporal-Kuhnke M, Jarius S, Haas J, Wildemann B J Neurol. 2023; 271(5):2866-2870.

PMID: 37962590 PMC: 11055762. DOI: 10.1007/s00415-023-12071-9.

References

Crew P, Abara W, MCCulley L, Waldron P, Kirkcaldy R, Weston E . Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series. Clin Infect Dis. 2018; 69(4):596-600. PMC: 6744347. DOI: 10.1093/cid/ciy958. View

Biedenbach D, Castanheira M, Jones R . Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection. Antimicrob Agents Chemother. 2010; 54(9):4009-11. PMC: 2934969. DOI: 10.1128/AAC.01812-09. View

Jorgensen J, Crawford S, Fiebelkorn K . Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J Clin Microbiol. 2005; 43(7):3162-71. PMC: 1169190. DOI: 10.1128/JCM.43.7.3162-3171.2005. View

Nolfi-Donegan D, Konar M, Vianzon V, MacNeil J, Cooper J, Lurie P . Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab. Emerg Infect Dis. 2018; 24(8). PMC: 6056112. DOI: 10.3201/eid2408.180228. View

Crew P, McNamara L, Waldron P, MCCulley L, Jones S, Bersoff-Matcha S . Unusual Neisseria species as a cause of infection in patients taking eculizumab. J Infect. 2018; 78(2):113-118. PMC: 7224403. DOI: 10.1016/j.jinf.2018.10.015. View